• 제목/요약/키워드: internal diseases

검색결과 4,349건 처리시간 0.028초

동의보감(東醫寶鑑) 내상문(內傷門) 방제(方劑)에 배합(配合)된 풍약(風藥)의 활용(活用)에 대한 고찰(考察) (A Study on the Application of Wind Herbs(風藥) Blended with Prescriptions for Internal Disease Range in Donguibogam)

  • 전지영;문구
    • 대한한의학방제학회지
    • /
    • 제17권2호
    • /
    • pp.1-20
    • /
    • 2009
  • The purpose of this study was to examine how exterior-relieving herbs are blended by each prescription with emphasis on Internal disease range of Donguibogam by limiting Wind herbs in exterior-relieving herbs to apply exterior-relieving herbs to internal diseases. Prescriptions mixed with exterior-relieving herbs is a prescription adding Bojungikgitang, Yijintang, Yimyosan, Yukilsan and Gilgyeongjigaktang. The mixed exterior-relieving herbs were diversely operated according to each prescription or medicines. However, the mixed exterior relieving herbs were mixed for rising yang & tonifying qi(升陽益氣) for the most part. The exterior-relieving herbs mixed with prescriptions had the total 15 kinds, Bupleuri Radix, Cimicifugae Rhizoma among them were mixed with prescriptions for the most part. In addition, two-kind mixed exterior-relieving herbs were utilized in order of Bupleuri Radix Cimicifuga Rhizoma and Bupleuri Radix Cimicifugae Rhizoma Notopterygii Rhizoma Ledebouriellae Radix. Taken together, Wind herbs is applied several purpose, so that it can contribute to treatment and prevention of internal diseases in present-day.

  • PDF

A Case of Cryptogenic Organizing Pneumonia after Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma

  • Kim, Ah ran;Yoo, Kwang Ha;Lee, Kye Young;Kim, Sun Jong;Kim, Hee Joung;Kim, Jun Hyun;Rhyu, Yong A
    • Tuberculosis and Respiratory Diseases
    • /
    • 제78권4호
    • /
    • pp.469-472
    • /
    • 2015
  • Cryptogenic organizing pneumonia (COP) is an inflammatory lung disease involving the distal bronchioles, respiratory bronchioles, bronchiolar ducts, and alveolae. The etiology is usually unknown; however, there are several known causes and associated systemic diseases. Corticosteroid therapy is the best treatment option and the prognosis of COP is good, with recovery in up to 80% of patients. We described a patient with in-operable hepatocellular carcinoma (HCC) undergoing chemoembolization with doxorubicin in a drug-eluting bead (DEB). COP developed in the patient after chemoembolization but resolved spontaneously in several months.

유방결핵 1예 (A Case of Mammary Tuberculosis)

  • 이종진;박상기;김애경;조해정;서지원;김주옥;김선영
    • Tuberculosis and Respiratory Diseases
    • /
    • 제42권4호
    • /
    • pp.584-587
    • /
    • 1995
  • 저자들은 좌측유방에 분비물이 동반된 무동의 종물을 주소로 내원한 젊은여성에서 일반적인 항생제투여 및 배농등의 치료에 반응하지 않아 실시한 세침흡인 및 생검상 만성 염증성 육아종성변화로 나타나 유방결핵으로 진단된 1예를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

  • PDF

Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab

  • Jung, Hye-In;Kim, Hyun Jung;Kim, Ji-Min;Lee, Ju Yup;Park, Kyung Sik;Cho, Kwang Bum;Lee, Yoo Jin
    • Journal of Yeungnam Medical Science
    • /
    • 제38권1호
    • /
    • pp.70-73
    • /
    • 2021
  • Relapsing polychondritis (RP) is a rare, progressive immune-mediated systemic inflammatory disease of unknown etiology, characterized by recurrent inflammation of cartilaginous structures. Approximately 30% of RP cases are associated with other autoimmune diseases. However, the co-occurrence of RP and Crohn disease (CD) has rarely been reported. Herein, we present a 35-year-old woman diagnosed with RP and CD, who was refractory to initial conventional medications, including azathioprine and glucocorticoid, but who subsequently responded to infliximab (IFX). For both diseases, remission was sustained with IFX. There has been no previous report regarding the successful treatment of co-existing RP and CD with IFX.

Anti-CD3 Antibody Induces IL-10-producing $CD4^+CD25^+$ Regulatory T Cells, Which Suppress T Cell Response in Rheumatoid Arthritis Patients

  • Yoon, Bo-Young;Cho, Mi-La;Hong, Yeon-Sik;Jhun, Joo-Yeon;Park, Mi-Kyung;Park, Kyung-Su;Park, Sung-Hwan;Kim, Ho-Youn
    • IMMUNE NETWORK
    • /
    • 제7권3호
    • /
    • pp.124-132
    • /
    • 2007
  • Background: Regulatory T cells (Tregs) have been investigated intensively for some decades. These cells regulate the immune system, prevent overactivated immune responses and can be used therapeutically. For rheumatoid arthritis (RA), understanding the functions and status of Tregs is an important step for understanding immune regulation in this autoimmune disease. Methods: We investigated the percentages, phenotypes and suppressive functions of $CD4^+CD25^+$ Tregs in peripheral blood (PB) of patients with RA. Results: The percentages were higher in the patients (n=12) than in healthy controls (n=10), and the cells expressed the $CD45RB^{low}$, CTLA-4 and CCR7 phenotypes. We also investigated the expression of Foxp3 and secretion of interleukin (IL)-10 induced $CD4^+CD25^+$ Tcells by anti-CD3 antibody treatment. A suppressive function of the patients' cells was shown through coculture with $CD4^+CD25^-$ T cells in vitro. Conclusion: We suggest that, despite their increased numbers and suppressive function, they manage the ongoing inflammation ineffectively. It might be possible to apply IL-10 to induce the proliferation of IL-10-producing Tregs as therapy for RA.

Implementing antimicrobial stewardship: lessons and perspectives from a university-affiliated tertiary hospital in Korea

  • Soo Jin Lee;Raeseok Lee;Sung-Yeon Cho;Dukhee Nho;Hye Lim Ahn;Dong-Gun Lee
    • The Korean journal of internal medicine
    • /
    • 제39권3호
    • /
    • pp.399-412
    • /
    • 2024
  • Antimicrobial stewardship programs (ASPs) can lower antibiotic use, decrease medical expenses, prevent the emergence of resistant bacteria, and enhance treatment for infectious diseases. This study summarizes the stepwise implementation and effects of ASPs in a single university-affiliated tertiary care hospital in Korea; it also presents future directions and challenges in resource-limited settings. At the study hospital, the core elements of the ASP such as leadership commitment, accountability, and operating system were established in 2000, then strengthened by the formation of the Antimicrobial Stewardship (AMS) Team in 2018. The actions of ASPs entail key components including a computerized restrictive antibiotic prescription system, prospective audit, post-prescription review through quantitative and qualitative intervention, and pharmacy-based interventions to optimize antibiotic usage. The AMS Team regularly tracked antibiotic use, the effects of interventions, and the resistance patterns of pathogens in the hospital. The reporting system was enhanced and standardized by participation in the Korea National Antimicrobial Use Analysis System, and educational efforts are ongoing. Stepwise implementation of the ASP and the efforts of the AMS Team have led to a substantial reduction in the overall consumption of antibiotics, particularly regarding injectables, and optimization of antibiotic use. Our experience highlights the importance of leadership, accountability, institution-specific interventions, and the AMS Team.

만성폐쇄성폐질환 환자 사망 원인 - 한 3차 병원 연구 (Cause of Death in COPD Patients of a Referral Hospital)

  • 김범준;홍상범;심태선;임채만;이상도;고윤석;김우성;김동순;김원동;오연목
    • Tuberculosis and Respiratory Diseases
    • /
    • 제60권5호
    • /
    • pp.510-515
    • /
    • 2006
  • 연구 배경 : 만성폐쇄성폐질환(COPD)은 45세 이상의 성인에서 국내 유병률 17.2%로 주요 질환이다. 하지만, 국내 COPD 환자의 사망원인에 대한 연구는 불충분한 상황이다. 이에 국내 COPD 환자 사망원인에 대해서 알아보고자 서울아산병원 의무기록을 후향적으로 조사하였다. 방 법 : 2003년 1년간 서울아산병원에서 COPD로 진료한 1,078명의 사망여부를 통계청에 의뢰하여 총 사망자 88명을 얻었고 이중 폐결핵 후유증, 기관지확장증, 폐암 등 암 환자를 제외한 후 남은 28명의 COPD 환자 대상으로 사망원인을 분석하였다. 결 과 : COPD 환자의 사망원인은 폐렴 등 호흡기 원인이 16명 (57%), 심장 원인 5명 (18%), 급사 3명 (11%), 기타 4명 (14%) 등이었다. 서울아산병원 내에서 사망한 환자와 외에서 사망한 환자의 호흡기 관련 사망이 각각 83%(10명/12명)과 38%(6명/16명)이었다 (P=0.05) $FEV_1$이 50%예측치보다 큰 환자와 작은 환자의 호흡기 관련 사망은 각각 43%과 55%이었다 (P=0.89). 결 론 : 국내 3차 병원에서 진료하는 COPD 환자의 사망 원인은 폐렴 등 호흡기 원인 다수를 차지한다.

A Case of Endobronchial Aspergilloma Associated with Foreign Body in Immunocompetent Patient without Underlying Lung Disease

  • Jung, Seung Won;Kim, Moo Woong;Cho, Soo Kyung;Kim, Hyun Uk;Lee, Dong Cheol;Yoon, Byeong Kab;Jeong, Jong Pil;Ko, Young Choon
    • Tuberculosis and Respiratory Diseases
    • /
    • 제74권5호
    • /
    • pp.231-234
    • /
    • 2013
  • Aspergillus causes a variety of clinical syndromes in the lung including tracheobronchial aspergillosis, invasive aspergillosis, chronic necrotizing pulmonary aspergillosis, allergic bronchopulmonary aspergillosis, and aspergilloma. Aspergilloma usually results from ingrowths of colonized Aspergillus in damaged bronchial tree, pulmonary cyst or cavities of patients with underlying lung diseases. There are a few reports on endobronchial aspergilloma without underlying pulmonary lesion. We have experienced a case of endobronchial aspergilloma associated with foreign body developed in an immunocompetent patient without underlying lung diseases. A 59-year-old man is being hospitalized with recurring hemoptysis for 5 months. X-ray and computed tomography scans of chest showed a nodular opacity in superior segment of left lower lobe. Fiberoptic bronchoscopy revealed an irregular, mass-like, brownish material which totally obstructed the sub-segmental bronchus and a foreign body in superior segmental bronchus of the lower left lobe. Histopathologic examinations of biopsy specimen revealed fungal hyphae, characteristic of Aspergillus species.